Details for New Drug Application (NDA): 210730
The generic ingredient in OLINVYK is oliceridine. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the oliceridine profile page.
Summary for 210730
| Tradename: | OLINVYK |
| Applicant: | Trevena |
| Ingredient: | oliceridine |
| Patents: | 5 |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for 210730
Generic Entry Date for 210730*:
Constraining patent/regulatory exclusivity:
Dosage:
SOLUTION;INTRAVENOUS |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Suppliers and Packaging for NDA: 210730
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| OLINVYK | oliceridine | SOLUTION;INTRAVENOUS | 210730 | NDA | Trevena, Inc. | 71308-011 | 71308-011-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (71308-011-10) / 1 mL in 1 VIAL, SINGLE-DOSE (71308-011-01) |
| OLINVYK | oliceridine | SOLUTION;INTRAVENOUS | 210730 | NDA | Trevena, Inc. | 71308-021 | 71308-021-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (71308-021-10) / 2 mL in 1 VIAL, SINGLE-DOSE (71308-021-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INTRAVENOUS | Strength | 1MG/ML (1MG/ML) | ||||
| Approval Date: | Oct 30, 2020 | TE: | RLD: | Yes | |||||
| Patent: | 11,077,098 | Patent Expiration: | Mar 23, 2032 | Product Flag? | Y | Substance Flag? | Y | Delist Request? | |
| Patented Use: | MANAGEMENT OF ACUTE PAIN BY INTRAVENOUS INJECTION | ||||||||
| Patent: | 11,931,350 | Patent Expiration: | Mar 23, 2032 | Product Flag? | Substance Flag? | Y | Delist Request? | ||
| Patented Use: | MANAGEMENT OF ACUTE PAIN BY INTRAVENOUS INJECTION | ||||||||
| Patent: | 8,835,488 | Patent Expiration: | Mar 23, 2032 | Product Flag? | Y | Substance Flag? | Y | Delist Request? | |
| Patented Use: | MANAGEMENT OF ACUTE PAIN BY INTRAVENOUS INJECTION | ||||||||
Complete Access Available with Subscription
